TABLE 3.
Logistic regression analysis of indexes that may affect the cure of RVO at 6 months.
| Risk index | β | OR | 95% confidence interval (CI) |
P value | |
| Lower limit | Upper limit | ||||
| Age | –0.060 | 0.942 | 0.880 | 1.007 | 0.080 |
| Disease subtype | –0.488 | 0.614 | 0.145 | 2.609 | 0.509 |
| Disease duration | –0.393 | 0.675 | 0.546 | 0.835 | < 0.001 |
| 2-week CMT | –0.018 | 0.982 | 0.974 | 0.990 | < 0.001 |
| 2-week CMT reduction rate >37% | 2.266 | 9.639 | 1.030 | 90.227 | 0.047 |
| 2-week BCVA (logMAR) | –2.443 | 0.087 | 0.012 | 0.609 | 0.014 |
During the effect risk index (P < 0.05), 2-week CMT reduction rate >37% is the best predictor for the cure at 6 months (OR = 9.639, 95% Cl = 1.030–90.227, P = 0.047). In addition, disease duration, 2-week CMT and 2-week BCVA (logMAR) are negative predictors for the cure of RVO at 6 months.